CytomX Therapeutics, Inc. (CTMX)
2.34
+0.05
(+2.18%)
USD |
NASDAQ |
Oct 30, 16:00
2.37
+0.03
(+1.28%)
After-Hours: 20:00
CytomX Therapeutics Price : 2.34 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.28 | 2.36 | 2.21 | 2.34 | 4.945M |
| Oct 29, 2026 | 2.38 | 2.42 | 2.25 | 2.29 | 4.629M |
| Oct 28, 2026 | 2.28 | 2.385 | 2.25 | 2.36 | 4.080M |
| Oct 27, 2026 | 2.21 | 2.36 | 2.16 | 2.31 | 3.734M |
| Oct 26, 2026 | 2.31 | 2.33 | 2.18 | 2.225 | 5.224M |
| Oct 23, 2026 | 2.41 | 2.42 | 2.305 | 2.32 | 4.366M |
| Oct 22, 2026 | 2.38 | 2.47 | 2.37 | 2.44 | 2.445M |
| Oct 21, 2026 | 2.525 | 2.61 | 2.39 | 2.40 | 3.111M |
| Oct 20, 2026 | 2.36 | 2.55 | 2.34 | 2.51 | 4.104M |
| Oct 19, 2026 | 2.31 | 2.35 | 2.24 | 2.34 | 2.049M |
| Oct 16, 2026 | 2.40 | 2.45 | 2.26 | 2.28 | 3.179M |
| Oct 15, 2026 | 2.26 | 2.435 | 2.25 | 2.41 | 2.986M |
| Oct 14, 2026 | 2.30 | 2.345 | 2.20 | 2.23 | 3.355M |
| Oct 13, 2026 | 2.45 | 2.45 | 2.32 | 2.325 | 5.223M |
| Oct 12, 2026 | 2.56 | 2.575 | 2.41 | 2.42 | 4.001M |
| Oct 09, 2026 | 2.46 | 2.58 | 2.44 | 2.57 | 3.041M |
| Oct 08, 2026 | 2.51 | 2.545 | 2.43 | 2.47 | 4.503M |
| Oct 07, 2026 | 2.53 | 2.65 | 2.52 | 2.55 | 2.341M |
| Oct 06, 2026 | 2.61 | 2.63 | 2.505 | 2.56 | 1.956M |
| Oct 05, 2026 | 2.55 | 2.67 | 2.48 | 2.58 | 1.767M |
| Oct 02, 2026 | 2.68 | 2.68 | 2.55 | 2.56 | 2.624M |
| Oct 01, 2026 | 2.71 | 2.775 | 2.62 | 2.63 | 2.698M |
| Sep 30, 2026 | 2.78 | 2.80 | 2.70 | 2.72 | 3.221M |
| Sep 29, 2026 | 2.70 | 2.825 | 2.65 | 2.75 | 4.457M |
| Sep 28, 2026 | 2.68 | 2.76 | 2.60 | 2.69 | 2.694M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 927.89 |
| ACADIA Pharmaceuticals, Inc. | 20.59 |
| Alnylam Pharmaceuticals, Inc. | 165.00 |
| Anika Therapeutics, Inc. | 20.95 |
| Savara, Inc. | 4.82 |
Price Related Metrics
| PS Ratio | 23.38 |
| Price to Book Value | 1.688 |
| Earnings Yield | -19.53% |
| Market Cap | 509.88M |